Mirum Pharmaceuticals Inc (MIRM)
25.11
+0.04
(+0.16%)
USD |
NASDAQ |
Apr 30, 16:00
25.11
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Gross Profit Margin (Quarterly): 64.03% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 64.03% |
| September 30, 2023 | 78.57% |
| June 30, 2023 | 81.83% |
| March 31, 2023 | 84.24% |
| December 31, 2022 | 83.90% |
| Date | Value |
|---|---|
| September 30, 2022 | 84.39% |
| June 30, 2022 | 85.56% |
| March 31, 2022 | 81.20% |
| December 31, 2021 | 39.36% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
39.36%
Minimum
Dec 2021
85.56%
Maximum
Jun 2022
75.90%
Average
81.83%
Median
Jun 2023
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences Inc | 76.79% |
| Vanda Pharmaceuticals Inc | 92.36% |
| Sarepta Therapeutics Inc | 88.87% |
| Puma Biotechnology Inc | 66.30% |
| Reneo Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -92.90% |
| Return on Assets | -33.66% |
| Return on Invested Capital | -45.45% |
| Profit Margin (Quarterly) | -51.27% |
| Operating Margin (Quarterly) | -46.85% |
| Return on Net Operating Assets | -85.06% |